John Buchanan delivered a presentation titled "The Discovery of 2,4-Bis-Arylamino-1,3-Pyrimidines as IGF-1R Kinase Inhibitors" at the Gordon Research Conference on Heterocyclic Compounds at Salve Regina University.
You May Also Be Interested In: